Compare ABCL & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ABCL | PCT |
|---|---|---|
| Founded | 2012 | 2015 |
| Country | Canada | United States |
| Employees | N/A | 174 |
| Industry | Biotechnology: Pharmaceutical Preparations | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 955.4M |
| IPO Year | 2020 | N/A |
| Metric | ABCL | PCT |
|---|---|---|
| Price | $3.51 | $5.38 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $7.75 | ★ $13.00 |
| AVG Volume (30 Days) | 2.3M | ★ 4.7M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.91 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $75,128,000.00 | N/A |
| Revenue This Year | N/A | $366.83 |
| Revenue Next Year | $25.44 | $201.87 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 160.56 | N/A |
| 52 Week Low | $1.89 | $4.93 |
| 52 Week High | $6.52 | $17.37 |
| Indicator | ABCL | PCT |
|---|---|---|
| Relative Strength Index (RSI) | 53.38 | 39.12 |
| Support Level | $3.37 | $5.12 |
| Resistance Level | $3.57 | $6.23 |
| Average True Range (ATR) | 0.15 | 0.48 |
| MACD | 0.01 | 0.09 |
| Stochastic Oscillator | 65.63 | 37.84 |
AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.